Sean N Tucker

4PUBLICATIONS
43CO-AUTHORS
Molecular targetsPreventative health careInnate immunityVeterinary virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 14, 2025
An oral norovirus vaccine generates mucosal immunity and reduces viral shedding in a phase 2 placebo-controlled challenge study.

Becca A Flitter, Joshua Gillard, Susan N Greco

|Mar 05, 2025
An oral norovirus vaccine tablet was safe and elicited mucosal immunity in older adults in a phase 1b clinical trial.

Becca A Flitter, Susan N Greco, Colin A Lester

|Mar 05, 2025
Broadly neutralizing antibodies targeting pandemic GII.4 variants or seven GII genotypes of human norovirus.

Juyeon Park, Lisa C Lindesmith, Adam S Olia

|May 05, 2022
Adenovirus type 5 SARS-CoV-2 vaccines delivered orally or intranasally reduced disease severity and transmission in a hamster model.

Stephanie N Langel, Susan Johnson, Clarissa I Martinez

Pageof 1